Aarti Drugs Buyback 2021 Record Date, Buyback Price & Details

Aarti Drugs Buyback 2023

Aarti Drugs Buyback 2021 announced on 19 March 2021. The Aarti Drugs buyback to start from 27 April 2021 to 10 May 2021. The Company will do Buyback with equity of 60,00,00 Equity Shares around 9.82% of Face Value Rs. 10/ Each Fully paid off at a Price Of Rs. 1000/- Per Equity. The size of this Buyback is about 60 Crores. And this will be done through a Buyback Tender Offer.

Let us know that Aarti Drugs Ltd. was established in the year 1984 and forms part of $900 Million Aarti Group of Industries with robust R&D Division at Tarapur, Maharashtra Industrial Development Corporation (MIDC) in close vicinity to manufacturing locations.

The Company is engaged in the manufacturing of Active Pharmaceutical Ingredients (APIs), Pharma Intermediates, Specialty Chemicals and also produces Formulations with its wholly-owned subsidiary – Pinnacle Life Science Private Limited. Products under APIs include Ciprofloxacin Hydrochloride, Metronidazole, Metformin HCL, Ketoconazole, Ofloxacin, etc. whereas Specialty Chemicals include Benzene Sulphonyl Chloride, Methyl Nicotinate, etc.

Aarti Drugs buyback 2021 Offer Details:

Event NameDetails
Buyback TypeTender Offer
Buyback Record Date1 Apr 2021
Buyback Offer Amount60 Cr
Date of Board Meeting approving the proposal19 March 2021
Date of Public Announcement19 March 2021
Buyback Offer Size9.82%
Buyback Number of Shares6,00,000
Price TypeTender Offer
Face ValueRs. 10/-
Buyback Price1000/- Rs.

Aarti Drugs Buyback 2021 Important Dates

We have covered all important dates related to “Aarti Drugs Buyback 2021” Buyback Activity Dates are updated as they are announced.

Buyback ActivityDates
Board Meeting for Buyback proposal19 March 2021
Buyback Approval date19 March 2021
Public Announcement Date22 March 2021
Buyback Record Date1 Apr 2021
Buyback Opening Date27 Apr 2021
Buyback Closing Date10 May 2021

Details Of The Buyback Offer and Offer Price :

Aarti Drugs Limited (“Company”) had announced the Buyback of up to 6,00,000 (Six Lakhs) fully paid-up equity shares of `10/- (Rupees Ten only) each of the Company (“Equity Shares”) representing up to 0.64% of the total number of issued, subscribed and paid-up Equity Shares of the Company at a price of `1000/- (Rupees One Thousand Only) per Equity Share (“Buyback Price”) payable in cash for an aggregate amount of up to `60,00,00,000/- (Rupees Sixty Crores only) (“Buyback Size”), which represents up to 9.82% and 9.41% of the fully paid-up equity share capital and free reserves as per the latest audited standalone and consolidated financial statements, respectively, for the year ended March 31, 2020, of the Company.

The “Audited Financial Statements” and the Buyback Size does not include transaction costs expenses incurred or to be incurred for the Buyback like filing fees payable to the Securities and Exchange Board of India (“SEBI”), advisors/legal fees, public announcement publication expenses, printing and dispatch expenses, brokerage, applicable taxes inter alia including Buyback taxes, securities transaction tax, GST, stamp duty, etc.

And other incidental and related expenses (“Transaction Cost”), out of the free reserves of the Company and/or such other permitted source by the Buyback Regulations or the Companies Act, on a proportionate basis through the Tender offer route as prescribed under the Buyback Regulations, to all of the shareholders of the Company who hold Equity Shares` as of the record date i.e. Thursday, April 01, 2021 (“Record Date”) (“Buyback”). The Buyback opened on Tuesday, April 27, 2021, and closed on Monday, May 10, 2021.

Buyback Public Announcement Link :

Buyback Link

Registrar of The Buyback :

Link Intime India Private Limited
Address: C-101, 1st Floor, 247 Park, L.B.S. Marg,
Vikhroli (West), Mumbai 400 083, Maharashtra, India
Phone: +91 22 4918 6200
Fax: +91 22 4918 6195
Email: [email protected]
Webiste: www.linkintime.co.in

Manager of The Buyback :

1229, Hubtown Solaris, N.S. Phadke Marg,
Opp. Telli Galli, Andheri (East), Mumbai 400069
Tel. No.: +91 022 26816003, Fax: +91 022 26816020;
Contact Person: Kavita Shah;
Email: [email protected];
Website: www.ingaventures.com

Company Address :

Aarti Drugs Ltd
Mahendra Industrial Estate, Ground Floor
Plot No. 109-D, Road No. 29, Sion (East),
Mumbai – 400 022, Maharastra

Tel. No.: +91 22 2404 8199
Fax: +91 22 2407 3462
Email: [email protected]
Website: www.aartidrugs.co.in

How to Participate in Aarti Drugs Ltd buyback?

The Investors are eligible for the buyback scheme who have Aarti Drugs shares in their Demat account as Record date 1 Apr 2021. Investors can participate in the Aarti Drugs Buyback 2021 scheme as per the opening form by selling their shares. The payment will be given as per the accepted shares by the company under the Aarti Drugs buyback scheme.

Aarti Drugs Buyback 2021 FAQs:

When is Aarti Drugs Buyback Announcement Date?
Aarti Drugs buyback 2021 announcement date is 22 March 2021.

When is Aarti Drugs Buyback Open Date?
Aarti Drugs buyback Open date is 27 Apr 2021

When is Aarti Drugs Buyback Close Date?
Aarti Drugs buyback Close date is 10 May 2021.

When is Aarti Drugs Buyback Record Date?
Aarti Drugs buyback 2021 Record date is 1 Apr 2021.

What is Aarti Drugs Buyback Price?
Aarti Drugs company has fixed the price at ₹1000 per share.

What is Aarti Drugs Buyback Offer Size?
Aarti Drugs company Buyback Offer Size is ₹60 Cr.

How to apply for Aarti Drugs Buyback 2021?
As per the record date you need to have Aarti Drugs shares in your Demat account. You can participate in buyback after having the stock in your account.


Aarti Drugs Buyback 2021 Record Date, Buyback Price & Details

Trade with LTP Calculator